Journal of Gastroenterology

, Volume 45, Issue 10, pp 1063–1071 | Cite as

Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma

  • Jianhua Yin
  • Jiaxin Xie
  • Hongwei Zhang
  • Qiuxia Shen
  • Lei Han
  • Wenying Lu
  • Yifang Han
  • Chengzhong Li
  • Wu Ni
  • Hongyang Wang
  • Guangwen Cao
Original Article—Liver, Pancreas, and Biliary Tract

Abstract

Background

The associations of nucleotide substitution mutations in the preS region of hepatitis B virus (HBV) with hepatocellular carcinoma (HCC) and cirrhosis remain unknown. We aimed to determine the associations of preS mutations with HCC or cirrhosis.

Methods

HBV from 603 asymptomatic hepatitis B surface antigen carriers (ASCs), 219 chronic hepatitis B (CHB) patients, 119 cirrhosis patients, and 231 HCC patients were genotyped and sequenced in the preS region. Nucleotides with the highest frequencies in HBV from the hepatitis B e antigen (HBeAg)-positive ASCs were treated as “wild-type” nucleotides. Twenty-one preS1 mutations and 14 preS2 mutations were evaluated. Multivariate regression analyses were applied to determine factors independently associated with cirrhosis or HCC.

Results

Most (85.7%) preS2 mutations were associated with CHB compared with ASCs, whereas most preS1 mutations were associated with HCC compared with the cirrhosis patients or CHB patients. Compared with the CHB patients, 81.0% preS1 mutations in genotype C were inversely associated with cirrhosis. Multivariate regression analyses showed that C2964A, C3116T, and C7A were novel factors associated with HCC compared with those without HCC, whereas A2964C and T3116C were independently associated with cirrhosis compared with ASCs and the CHB patients. Combined preS1 mutations had specificities greater than 95%, while C3116T and C7A had moderate sensitivities and specificities, for HCC.

Conclusions

C2964A, C3116T, and C7A are novel markers independently associated with an increased risk of HCC, while A2964C and T3116C are novel markers independently associated with an increased risk of cirrhosis. Combined preS1 mutations are specific for HCC.

Keywords

Hepatitis B virus Mutation PreS Hepatocellular carcinoma Liver cirrhosis 

Abbreviations

ALT

Alanine aminotransferase

AOR

Adjusted odds ratio

ASC

Asymptomatic hepatitis B surface antigen carrier

CHB

Chronic hepatitis B

HBV

Hepatitis B virus

HBeAg

Hepatitis B e antigen

HBsAg

Hepatitis B surface antigen

HCC

Hepatocellular carcinoma

LC

Liver cirrhosis

Notes

Acknowledgments

We thank the members of our epidemiological teams for their help in field epidemiological study. This work was supported by grants from Ministry of Health of China (2008ZX10002-15), National Natural Science Foundation of China (30921006, 30901272), and Shanghai Science & Technology Committee (08XD14001).

Conflict of interest statement

No conflicts of interest exist.

References

  1. 1.
    Nguyen VT, Law MG, Dore GJ. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden. J Viral Hepat. 2009;16:453–63.CrossRefPubMedGoogle Scholar
  2. 2.
    Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res. 2007;127:164–76.CrossRefPubMedGoogle Scholar
  3. 3.
    Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat. 2005;12:111–24.CrossRefPubMedGoogle Scholar
  4. 4.
    Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol. 2009;15:5761–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Sugauchi F, Ohno T, Orito E, Sakugawa H, Ichida T, Komatsu M, et al. Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease. J Med Virol. 2003;70:537–44.CrossRefPubMedGoogle Scholar
  6. 6.
    Gao ZY, Li T, Wang J, Du JM, Li YJ, Li J, et al. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol. 2007;42:761–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol. 2009;50:264–72.CrossRefPubMedGoogle Scholar
  8. 8.
    Chen CH, Hung CH, Lee CM, Hu TH, Wang JH, Wang JC, et al. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients. Gastroenterology. 2007;133:1466–74.CrossRefPubMedGoogle Scholar
  9. 9.
    Fang ZL, Sabin CA, Dong BQ, Wei SC, Chen QY, Fang KX, et al. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study. J Gen Virol. 2008;89(Pt 11):2882–90.CrossRefPubMedGoogle Scholar
  10. 10.
    Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology. 2006;130:1153–68.CrossRefPubMedGoogle Scholar
  11. 11.
    Choi MS, Kim DY, Lee DH, Lee JH, Koh KC, Paik SW, et al. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat. 2007;14:161–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis. J Natl Cancer Inst. 2009;101:1066–82.CrossRefPubMedGoogle Scholar
  13. 13.
    Yin J, Zhang H, He Y, Xie J, Liu L, Chang W, et al. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Cancer Epidemiol Biomarkers Prev. 2010;19:777–86.CrossRefPubMedGoogle Scholar
  14. 14.
    Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507–39.CrossRefPubMedGoogle Scholar
  15. 15.
    Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut. 2008;57:1713–20.CrossRefPubMedGoogle Scholar
  16. 16.
    Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis. 2008;29:1685–91.CrossRefPubMedGoogle Scholar
  17. 17.
    Chen J, Yin J, Tan X, Zhang H, Chen B, Chang W, et al. Improved multiplex-PCR to identify hepatitis B virus genotypes A–F and subgenotypes B1, B2, C1 and C2. J Clin Virol. 2007;38:238–43.CrossRefPubMedGoogle Scholar
  18. 18.
    Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Qin Y, Zhang J, Mao R, Guo H, Yin Y, Wu X, et al. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers. J Med Virol. 2009;81:807–14.CrossRefPubMedGoogle Scholar
  20. 20.
    Choi JW, Ahn SH, Park JY, Chang HY, Kim JK, Baatarkhuu O, et al. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients. J Med Virol. 2009;81:594–601.CrossRefPubMedGoogle Scholar
  21. 21.
    Frelin L, Wahlström T, Tucker AE, Jones J, Hughes J, Lee BO, et al. A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection. J Virol. 2009;83:1379–92.CrossRefPubMedGoogle Scholar
  22. 22.
    Chan HL, Wong GL, Tse CH, Chim AM, Yiu KK, Chan HY, et al. Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B. Clin Gastroenterol Hepatol. 2009;7:1361–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265–72.CrossRefPubMedGoogle Scholar
  24. 24.
    Yuen MF, Tanaka Y, Fong DY, Fung J, Wong DK, Yuen JC, et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. J Hepatol. 2009;50:80–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Sung JJ, Tsui SK, Tse CH, Ng EY, Leung KS, Lee KH, et al. Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. J Virol. 2008;82:3604–11.CrossRefPubMedGoogle Scholar
  26. 26.
    Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis. 2004;25:2023–32.CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2010

Authors and Affiliations

  • Jianhua Yin
    • 1
  • Jiaxin Xie
    • 1
  • Hongwei Zhang
    • 1
  • Qiuxia Shen
    • 1
  • Lei Han
    • 1
  • Wenying Lu
    • 1
  • Yifang Han
    • 1
  • Chengzhong Li
    • 2
  • Wu Ni
    • 3
  • Hongyang Wang
    • 4
  • Guangwen Cao
    • 1
  1. 1.Department of EpidemiologySecond Military Medical UniversityShanghaiChina
  2. 2.Department of Infectious Disease, The 1st Affiliated HospitalSecond Military Medical UniversityShanghaiChina
  3. 3.Department of Infectious Disease, The 2nd Affiliated HospitalSecond Military Medical UniversityShanghaiChina
  4. 4.Laboratory for Signal Transduction, The 3rd Affiliated HospitalSecond Military Medical UniversityShanghaiChina

Personalised recommendations